MedTrace Logo

Impact of Vaccine Funding by the National Health Insurance on Vaccination Coverage Among Patients Targeted by Current Vaccination Recommendations and Followed in Outpatient Consultations

NCT07243236 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2920

Last updated 2026-04-08

No results posted yet for this study

Summary

The objective of our study is to evaluate the impact of vaccine funding for patients seen in outpatient consultations within four healthcare institutions in the Ile-de-France region in France, made possible through the establishment of a tripartite agreement between the hospital group, the Île-de-France Regional Health Agency (ARS IDF), and the Primary Health Insurance Fund (CPAM).

Conditions

  • Healthcare Providers
  • Postpartum

Interventions

OTHER

Questionnaires for patients

Questionnaires for patients

OTHER

Questionnaires for healthcare providers

Questionnaires for healthcare providers

Sponsors & Collaborators

  • Agence régionale de santé Ile de France

    collaborator UNKNOWN

  • Institut de Recherche en Santé Publique, France

    collaborator OTHER

  • URC-CIC Paris Descartes Necker Cochin

    collaborator OTHER

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Marie LACHATRE, MD · Hôpital Cochin - APHP

  • Muriel BELIAH-NAPPEZ, MD · Agence régionale de santé Ile de France

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-11-19
Primary Completion
2027-05-31
Completion
2027-07-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07243236 on ClinicalTrials.gov